Wellmont Medical Associates Oncology and Hematology-Kingsport — Kingsport, Tennessee

Wellmont Medical Associates Oncology and Hematology-Kingsport is a clinical research site located in Kingsport, Tennessee, United States 37660.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Wellmont Medical Associates Oncology and Hematology-Kingsport has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Lymphoma, Mantle Cell Lymphoma, Extensive Stage Small Cell Lung Carcinoma.

Sponsors: Eastern Cooperative Oncology Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wellmont Medical Associates Oncology and Hematology-Kingsport?

Wellmont Medical Associates Oncology and Hematology-Kingsport has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wellmont Medical Associates Oncology and Hematology-Kingsport conducted?

Wellmont Medical Associates Oncology and Hematology-Kingsport has 8 clinical trials on record, with 1 currently active. Their work covers Lymphoma, Mantle Cell Lymphoma, Extensive Stage Small Cell Lung Carcinoma.

Is Wellmont Medical Associates Oncology and Hematology-Kingsport accredited by Crixeo Health?

Yes — Wellmont Medical Associates Oncology and Hematology-Kingsport holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Wellmont Medical Associates Oncology and Hematology-Kingsport?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.